Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 28:2021:9938658.
doi: 10.1155/2021/9938658. eCollection 2021.

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

Qiulan Huang  1 , Yanting Huang  1 , Jianping Liu  1
Affiliations
Review

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

Qiulan Huang et al. Int J Endocrinol. .

Abstract

Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Mechanisms of MSC therapy for DM.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cañibano-Hernández A., Sáenz Del Burgo L., Espona-Noguera A., Ciriza J., Pedraz J. L. Current advanced therapy cell-based medicinal products for type-1-diabetes treatment. International Journal of Pharmaceutics. 2018;543(1–2):107–120. doi: 10.1016/j.ijpharm.2018.03.041. - DOI - PubMed
    1. Raz I., Riddle M. C., Rosenstock J., et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care. Diabetes Care. 2013;36(6):1779–1788. doi: 10.2337/dc13-0512. - DOI - PMC - PubMed
    1. McCall M., Shapiro A. M. Update on islet transplantation. Cold Spring Harbor Perspectives in Medicine. 2012;2(7) doi: 10.1101/cshperspect.a007823.a007823 - DOI - PMC - PubMed
    1. Shapiro A. M. J., Lakey J. R. T., Ryan E. A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine. 2000;343(4):230–238. doi: 10.1056/nejm200007273430401. - DOI - PubMed
    1. Gamble A., Pepper A. R., Bruni A., Shapiro A. M. J. The journey of islet cell transplantation and future development. Islets. 2018;10(2):80–94. doi: 10.1080/19382014.2018.1428511. - DOI - PMC - PubMed

LinkOut - more resources